17 Bottles of Cough Syrup: Do They Fall Under Manufactured Drugs in NDPS Act?

In the world of pharmaceuticals and narcotics law, few questions spark as much confusion as whether common medicines like cough syrups containing codeine are classified as manufactured drugs under India's Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985. Imagine a scenario where 17 bottles of cough syrup are seized—does this automatically trigger NDPS penalties? The question at hand is: 17 bottles of Cough Syrup Fall under Manufacture Drugs or Not?

This blog post dives deep into the legal nuances, drawing from court judgments, notifications, and regulatory frameworks. We'll clarify when such syrups are exempt, the critical role of composition and intent, and key judicial precedents. Note: This is general information based on legal precedents and not specific legal advice. Consult a qualified lawyer for your case.

Understanding Manufactured Drugs Under the NDPS Act

The NDPS Act strictly regulates narcotic drugs and psychotropic substances to curb abuse. Section 2(xi)(b) defines manufactured drug as any narcotic substance or preparation declared by the Central Government via notifications. However, not all codeine-based products qualify.

Cough syrups with codeine, when used therapeutically, often fall under the Drugs and Cosmetics Act, 1940—specifically Schedule H—rather than NDPS. The classification hinges on composition, quantity, purpose, and licensing2024 0 Supreme(Guj) 508 2021 0 Supreme(Ori) 168.

Key Points:- Therapeutic cough syrups with codeine below specified limits are exempted from NDPS.- Exceeding limits or illicit intent shifts them to contraband status.- Courts emphasize prima facie compliance with exemptions 2021 0 Supreme(Del) 383.

Legal Definitions and Key Notifications

A pivotal exemption comes from Notification No. S.O. 826(E) dated 14.11.1985, which states: Codeine and its salts, all dilutions and preparations containing not more than 100 mg per dosage unit and not more than 2.5% in undivided preparations, established in therapeutic practice, are exempted from NDPS classification. These are governed by Schedule H of the Drugs and Cosmetics Rules 2024 0 Supreme(Guj) 508.

In the case of the 17 bottles, documents reveal the syrup contains approximately 10 mg of codeine phosphate per 5 ml, well below 100 mg per dosage unit and under 2.5% concentration. As quoted: the label affixed to each bottle declared that it contains Codeine Phosphate in the ratio of 10 milligrams per 5 milliliters of syrup and both syrups contained Codeine Phosphate in proportion of 10 milligrams per 5 m.ls., which would surely be less than 2.5% in concentration in undivided preparations 2024 0 Supreme(Guj) 508 2021 0 Supreme(Ori) 168.

This aligns with legal principles: such compositions for medicinal use are not manufactured drugs under NDPS but Schedule H drugs

Bikash Duria VS State of Odisha - Crimes (2020)

Composition and Quantity Analysis

Quantity matters, but not in isolation. For the 17 bottles:- Codeine content: 10 mg/5 ml, compliant with notification thresholds.- Total volume: Typically 100 ml per bottle, but pure codeine is minimal (e.g., around 0.17% in similar cases) 2020 0 Supreme(Del) 763.

Other sources confirm: Reputed firms like those producing Phensedyl, Onerex, RC-KUFFS, Welcyrex, and Plencyrex manufacture under valid licenses with codeine within prescribed quantity. Both firms are reputed and having valid license for manufacturing medicines. Admittedly, Phensedyl Cough Syrup contains 'codeine' within the prescribed quantity 2021 0 Supreme(All) 444.

Without chemical analysis proving excess, courts lean towards exemption, especially for small quantities like 17 or 28 bottles, where codeine doesn't reach commercial levels 2017 0 Supreme(J&K) 617.

Purpose, Licensing, and Documentation

Intent is crucial. If procured under valid licenses for therapeutic supply to medicine shops, it's a Schedule H drug. As noted: the content of codeine phosphate in the cough syrup was less than 100 mgs per dosage unit and less than 2.5 % in undivided preparations and as it was meant for supply to licensed medicine shops it is a Schedule H drug

Bikash Duria VS State of Odisha - Crimes (2020)

Additional cases echo this: Cough syrups transported or stored under licenses (e.g., 21,600 bottles) are not automatically NDPS contraband if compliant 2020 0 Supreme(All) 1482. Lack of analysis reports doesn't presume guilt; it supports exemption claims

MANOJ KUMAR BHUYAN vs STATE OF ODISHA - Orissa

MRUTYUNJAY SAHOO vs STATE OF ODISHA - Orissa

JYOTISH KUMAR KANUNGO vs STATE OF ODISHA - Orissa

Judicial Precedents and Court Rulings

Indian courts have consistently ruled in favor of exemptions for compliant cough syrups:- Iqbal Singh case: The learned Single Judge... was of the prima facie view that the cough syrup containing Codeine would not fall within the definition of ‘manufactured drug’ MANOJ KUMAR BHUYAN vs STATE OF ODISHA - Orissa_Delhi_BAIL_APPLN-1136_2021 2022_DHC_3673-DB.- Supreme Court in Mohd. Sahabuddin v. State of Assam: Quantity of mixture considered, but therapeutic use within limits avoids NDPS 2021 0 Supreme(Del) 383.- Iqbal Singh decision: Medicinal preparations below threshold not narcotic drugs 2022 0 Supreme(Del) 1905.- Phensedyl and similar: Phensedyl cough syrup... is required to be considered as a drug under the Drugs and Cosmetics Act... Codeine in 28 bottles doesn't hit commercial quantity 2017 0 Supreme(J&K) 617.

Courts stress: Licensed products like Phensedyl (182-189 mg/100 ml) for therapy are Schedule H, openly sold 2025 0 Supreme(Jhk) 1226 2022 0 Supreme(Del) 1905.

Exceptions and When It Could Be Contraband

Exemptions aren't absolute:- Exceeding limits: >100 mg/dosage or >2.5% concentration triggers NDPS 2024 0 Supreme(Guj) 508.- Illicit purpose: Diversion for abuse, lack of licenses, or no documentation classifies as contraband 2021 0 Supreme(Ori) 168.- Even small quantities (e.g., 17 bottles) risk penalties if proven non-therapeutic.

As in transport cases with banned amounts, ignorance of composition doesn't always excuse 2020 0 Supreme(All) 1482.

Practical Recommendations

To defend against NDPS claims:- Produce licenses, invoices, waybills, and chemical reports proving compliance

Bikash Duria VS State of Odisha - Crimes (2020)

For businesses: Ensure documentation trails; concentrations like 183 mg/100 ml are safe if licensed 2025 0 Supreme(Jhk) 1226.

Conclusion and Key Takeaways

Generally, 17 bottles of cough syrup do not fall under manufactured drugs per NDPS if codeine is <100 mg/dosage, <2.5% concentration, therapeutically intended, and licensed. They align with Schedule H, not NDPS contraband 2024 0 Supreme(Guj) 508 2021 0 Supreme(Ori) 168 2022 0 Supreme(Del) 1905.

Key Takeaways:- Composition first: Check against 1985 notification.- Proof matters: Licenses trump assumptions.- Courts protect therapy: Small, compliant quantities often exempted.- Caution: Illicit use changes everything.

Stay informed on NDPS updates. For personalized guidance, seek legal experts. This analysis draws from precedents like 2021 0 Supreme(Del) 383, MANOJ KUMAR BHUYAN vs STATE OF ODISHA - Orissa_Delhi_BAIL_APPLN-1136_2021 2022_DHC_3673-DB, ensuring a balanced view.